Compare MOFG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOFG | PSNL |
|---|---|---|
| Founded | 1934 | 2011 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.6M | 729.1M |
| IPO Year | N/A | N/A |
| Metric | MOFG | PSNL |
|---|---|---|
| Price | $49.17 | $8.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $40.50 | $11.33 |
| AVG Volume (30 Days) | 204.8K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $242.68 | N/A |
| Revenue Next Year | $7.66 | $19.41 |
| P/E Ratio | $17.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.62 | $2.83 |
| 52 Week High | $49.69 | $11.50 |
| Indicator | MOFG | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 75.63 | 47.43 |
| Support Level | $47.16 | $7.95 |
| Resistance Level | $49.26 | $9.04 |
| Average True Range (ATR) | 1.22 | 0.74 |
| MACD | 0.05 | -0.10 |
| Stochastic Oscillator | 92.35 | 40.25 |
MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.